Federation Des Caisses Desjardins Du Quebec Novartis Ag Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Novartis Ag stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 8,503 shares of NVS stock, worth $836,270. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,503
Previous 8,527 0.28%
Holding current value
$836,270
Previous $907,000 7.83%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $2,547 - $2,901
-24 Reduced 0.28%
8,503 $978,000
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $96,828 - $112,309
-1,046 Reduced 10.93%
8,527 $907,000
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $912,019 - $1.04 Million
9,573 New
9,573 $926 Million
Q4 2023

Aug 14, 2024
SELL
$92.27 - $101.54 $125,948 - $138,602
-1,365 Reduced 2.03%
65,723 $6.64 Billion
Q3 2023

Aug 14, 2024
BUY
$94.73 - $105.13 $5.55 Million - $6.16 Million
58,603 Added 690.67%
67,088 $6.83 Billion
Q2 2023

Aug 14, 2024
SELL
$92.52 - $104.91 $6,661 - $7,553
-72 Reduced 0.84%
8,485 $856 Million
Q1 2023

Aug 14, 2024
SELL
$80.03 - $92.81 $152,377 - $176,710
-1,904 Reduced 18.2%
8,557 $787 Million
Q4 2022

Aug 14, 2024
SELL
$75.55 - $92.52 $9,821 - $12,027
-130 Reduced 1.23%
10,461 $949 Million
Q3 2022

Aug 14, 2024
BUY
$74.61 - $87.26 $4,924 - $5,759
66 Added 0.63%
10,591 $805 Million
Q2 2022

Aug 14, 2024
SELL
$80.52 - $93.75 $13,366 - $15,562
-166 Reduced 1.55%
10,525 $890 Million
Q1 2022

Aug 14, 2024
BUY
$80.11 - $90.62 $173,358 - $196,101
2,164 Added 25.38%
10,691 $938 Million
Q4 2021

Aug 30, 2024
SELL
$79.7 - $88.13 $14,186 - $15,687
-178 Reduced 1.66%
10,517 $920 Million
Q3 2021

Aug 30, 2024
BUY
$81.78 - $95.14 $6,787 - $7,896
83 Added 0.78%
10,695 $875 Million
Q2 2021

Aug 30, 2024
BUY
$85.24 - $94.15 $177,725 - $196,302
2,085 Added 24.45%
10,612 $968 Million
Q1 2021

Aug 30, 2024
SELL
$83.5 - $98.47 $37,658 - $44,409
-451 Reduced 3.06%
14,293 $1.22 Billion
Q4 2020

Aug 30, 2024
SELL
$78.07 - $94.43 $71,590 - $86,592
-917 Reduced 5.86%
14,744 $1.39 Billion
Q3 2020

Aug 30, 2024
BUY
$82.14 - $91.0 $47,312 - $52,416
576 Added 3.82%
15,661 $1.36 Billion
Q2 2020

Aug 30, 2024
BUY
$80.93 - $91.1 $30,186 - $33,980
373 Added 2.54%
15,085 $1.32 Billion
Q1 2020

Aug 30, 2024
BUY
$70.67 - $99.01 $20,988 - $29,405
297 Added 2.06%
14,712 $1.21 Billion
Q4 2019

Aug 30, 2024
BUY
$84.35 - $95.37 $7,338 - $8,297
87 Added 0.61%
14,415 $1.36 Billion
Q3 2019

Aug 30, 2024
BUY
$85.54 - $94.26 $36,867 - $40,626
431 Added 3.1%
14,328 $1.25 Billion
Q2 2019

Aug 30, 2024
SELL
$75.4 - $92.8 $68,387 - $84,169
-907 Reduced 6.13%
13,897 $1.27 Billion
Q1 2019

Aug 30, 2024
SELL
$75.32 - $86.15 $950,463 - $1.09 Million
-12,619 Reduced 46.02%
14,804 $1.42 Billion
Q4 2018

Aug 30, 2024
BUY
$73.66 - $82.02 $1.39 Million - $1.55 Million
18,896 Added 221.6%
27,423 $2.35 Billion
Q3 2018

Aug 30, 2024
BUY
$66.94 - $77.43 $73,834 - $85,405
1,103 Added 4.52%
25,491 $2.2 Billion
Q2 2018

Aug 30, 2024
SELL
$64.91 - $73.36 $12,138 - $13,718
-187 Reduced 0.76%
24,388 $1.84 Billion
Q1 2018

Aug 30, 2024
SELL
$70.39 - $84.15 $48,428 - $57,895
-688 Reduced 2.72%
24,575 $1.99 Billion
Q4 2017

Aug 30, 2024
BUY
$72.33 - $77.64 $22,783 - $24,456
315 Added 1.26%
25,263 $2.12 Billion
Q3 2017

Aug 30, 2024
SELL
$74.14 - $77.27 $493,624 - $514,463
-6,658 Reduced 21.07%
24,948 $2.14 Billion
Q2 2017

Aug 30, 2024
BUY
N/A
23,079
31,606 $2.64 Billion

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email